Recent regulations have been discussed to restrict the sale of e-cigarettes, those electronic vaporizers that deliver nicotine without the flame, to prevent sale to minors, and to restrict advertising. From a medical standpoint, this is a very good thing, as the devices can serve as an entry port for young people to begin smoking. Here is a feature on MedPageToday, including my comments on this proposal:
Monday, August 25, 2014
I was fortunate to appear on WBAL-TV, our local NBC affiliate, tonight with a two minute health segment about osteoporosis. There are a few take home points from this video, which may help prevent this disease which many assume to be inevitable. Watch and enjoy. If you have any questions, feel free to post!
Wednesday, August 20, 2014
We all see those paper sheets with prescriptions or the teeny tiny print on medicine bottles that tell us all kinds of important information that don't, or can't read. What if there were a way to present that information in a form that would be both easier to read, and of more overall use? That was the question behind this Fox News piece, with my input of course, on:
Thursday, August 14, 2014
Several recently published studies have suggested that salt may not be as central to blood pressure management as we have all thought, but these studies also all admit that there are potential flaws in their methods, and that much more research is needed. Whether or not a change in therapy is needed remains the question, and I was asked to comment on that for the MedPageToday website:
Wednesday, July 30, 2014
Tuesday, July 29, 2014
Here's an interesting little article on the NowU.com website that asked me to contribute some ideas about problems that both men and women may be having in bed. If there is interest, I could be convinced to post all of my suggestions, along with those that made it into this article. Just leave some comments and tell your friends!
Friday, July 25, 2014
People with a variety of medical conditions require anti-coagulation, medications that interfere with normal blood clotting. While the most common oral medication used has long been warfarin, commonly known by the brand name Coumadin, a new group of drugs has recently been introduced, which promise freedom from the dietary restrictions and periodic blood tests that warfarin requires. Now, an article in the British Medical Journal discusses questions about the process that brought the first of these drugs, Pradaxa, to market. The MedPageToday website asked for my thoughts on this situation: